Reduced G protein functions and immunoreactive levels in mononuclear leukocytes of patients with depression

American Journal of Psychiatry

Volumn 154, Issue 2, 1997, Pages 211-217

  Avissar, Sofia ^a   Nechamkin, Yakov ^a   Roitman, Gregori ^a   Schreiber, Gabriel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; MONOCYTE; PRIORITY JOURNAL;

EID: 0031029294     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.2.211     Document Type: Article

References (50)

1. Gilman AG: G proteins: transducers of receptor-generated signals. Annu Rev Biochem 1987; 56:615-649
2. Hepler JR, Gilman AG: G proteins. Trends Biochem Sci 1992; 17:383-387
3. Cassel D, Selinger Z: Mechanism of adenylate cyclase activation through the β-adrenergic receptor: catecholamine-induced displacement of bound GDP by GTP. Proc Natl Acad Sci USA 1978; 75:4155-4159
4. 3H)-GDP release from rat and hamster adipocyte membranes independently linked to receptors involved in activation or inhibition of adenylate cyclase. J Biol Chem 1984; 259:761-769
5. Sternweis PC, Robishaw JD: Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain. J Biol Chem 1984; 259:13806-13813
6. Fergusson KM, Higashijima T, Smigel MD, Gilman AG: The influence of bound GDP on the kinetics of guanine nucleotide binding to G proteins. J Biol Chem 1986; 261:7393-7399
7. Northup JK, Smigel MD, Gilman AG: The guanine nucleotide activating site of the regulatory component of adenylate cyclase: identification by ligand binding. J Biol Chem 1982; 257:11416-11423
8. Kurose H, Katada T, Haga T, Haga K, Ichiyama A, Ui M: Functional interaction of purified muscarinic receptors with purified inhibitory guanine nucleotide regulatory proteins reconstituted in phospholipid vesicles. J Biol Chem 1986; 261:6423-6428
9. Evans SW, Beckner SK, Farrar WL: Stimulation of specific GTP binding and hydrolysis activities in lymphocyte membranes by IL-2. Nature 1987; 325:166-168
10. Avissar S, Schreiber G, Danon A, Belmaker RH: Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 1988; 331:440-442
11. Avissar S, Schreiber G: Muscarinic receptor subclassification and G proteins: significance for lithium action in affective disorders and for the treatment of the extra pyramidal side effects of neuroleptics. Biol Psychiatry 1989; 26:113-130
12. Avissar S, Murphy DL, Schreiber G: Magnesium reverses lithium inhibition of beta adrenergic and muscarinic receptor coupling to G proteins. Biochem Pharmacol 1991; 41:171-175
13. Schreiber G, Avissar S, Aulakh CS, Murphy DL: Lithium-selective alteration of the function of brain versus cardiac Gs protein. Neuropharmacology 1990; 29:1067-1071
14. Avissar S, Schreiber G: The involvement of G proteins in the pathogenesis and treatment of affective disorders. Biol Psychiatry 1992; 31:435-459
15. Avissar S, Schreiber G: Interaction of antibipolar and antidepressant treatments with receptor-coupled G proteins. Pharmacopsychiatry 1992; 25:44-50
16. Avissar S, Schreiber G, Aulakh CS, Wozniak KM, Murphy DL: Carbamazepine and electroconvulsive shock attenuate beta-adrenoceptor and muscarinic cholinoceptor coupling to G proteins in rat cortex. Eur J Pharmacol 1990; 189:99-103
17. Meyniel G, Doly M, Gaillard G: [Electrophysiological demonstration of transducin inhibition by lithium]. C R Acad Sci III 1989; 309:289-294 (French)
18. Mork A, Geisler A: Effects of GTP on hormone-stimulated adenylate cyclase activity in cerebral cortex, striatum and hippocampus from rats treated chronically with lithium. Biol Psychiatry 1989; 26:279-288
19. Newman ME, Shapira B, Lerer B: Effects of lithium and desipramine on second messenger responses in rat hippocampus: relation to G protein effects. Neuropharmacology 1991; 30:1297-1301
20. Manji HK, Bitran J, Masana M, Chen G, Hsiao JK, Risby ED, Rudorfer MW, Potter WZ: Signal transduction modulation by lithium: cell culture, cerebral microdialysis and human studies. Psychopharmacol Bull 1991; 27:199-208
21. Song L, Jope RS: Chronic lithium treatment impairs phosphatidylinositol hydrolysis in membranes from rat brain regions. J Neurochem 1992; 58:2200-2206
22. i-2 α-subunit mRNA levels in rat cortex. Eur J Pharmacol 1991; 206:165-166
23. i alpha protein in rat brain. Eur J Pharmacol 1991; 207:355-359
24. Schreiber G, Avissar S: Lithium sensitive G protein hyperfunction: a dynamic model for the pathogenesis of bipolar affective disorder. Med Hypotheses 1991; 35:237-243
25. Schreiber G, Avissar S, Danon A, Belmaker RH: Hyperfunctional G proteins in mononuclear leukocytes of patients with mania. Biol Psychiatry 1990; 29:273-280
26. Avissar S, Barki-Harrington L, Nechamkin Y, Roitman G, Schreiber G: Reduced β-adrenergic receptor-coupled Gs protein function in mononuclear leukocytes of patients with depression. Biol Psychiatry 1996; 39:755-760
27. Friedman E, Butkerait P, Wang HY: Analysis of receptor-stimulated and basal guanine nucleotide binding to membrane G proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal Biochem 1993; 214:171-178
28. Friedman E, Wang HY: Enhanced coupling of serotonin receptor/G proteins in postmortem brains of bipolar disorder patients, in The 2nd International Conference on New Directions in Affective Disorders. Edited by Lerer B. Jerusalem, KENES, 1995, p S29
29. Young LT, Li PP, Kamble A, Siu KP, Warsh JJ: Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressive disorder. Am J Psychiatry 1994; 151:594-596
30. sα subunit levels are elevated in bipolar affective disorder. Brain Res 1991; 553:323-326
31. Young LT, Li PP, Kish SJ, Siu KP, Kamble A, Hornykiewics O, Warsh JJ: Cerebral cortex Gs protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J Neurochem 1993; 61:890-898
32. Barki-Harrington L, Nechamkin Y, Schreiber G, Avissar S: Functional and quantitative measures of receptor coupled G proteins in human mononuclear leukocytes: no change with age. Exp Gerontol 1996; 31:351-363
33. Beck AT, Rush AJ, Show B, Emery G: Cognitive Therapy of Depression. New York, Guilford Press, 1979
34. Boyum A: Separation of leukocytes from blood and bone marrow: introduction. Scand J Clin Lab Invest Suppl 1968; 97:7
35. Glantz SA: Biostatistics, 3rd ed. New York, McGraw-Hill, 1992
36. Schatzberg AF, Schildkraut JJ: Recent studies on norepinephrine systems in mood disorders, in Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. New York, Raven Press, 1995, pp 911-920
37. Janowsky DS, Overstreet DH: The role of acetylcholine mechanisms in mood disorders. Ibid, pp 945-956
38. Inglese J, Freedman NJ, Koch WJ, Lefkowitz RJ: Structure and mechanism of G protein-coupled receptor kinases. J Biol Chem 1993; 268:23735-23738
39. Bauer PH, Muller S, Puzicha M, Pippig S, Obermaier B, Helmreich EJ, Lohse MJ: Phosducin is a protein kinase A-regulated G-protein regulator. Nature 1992; 358:73-76
40. Extein I, Tallman J, Smith CC, Goodwin FK: Changes in lymphocyte beta-adrenergic receptors in depression and mania. Psychiatry Res 1979; 1:191-197
41. Pandey GN, Janicak PG, Davis JM: Decreased beta-adrenergic receptors in the leukocytes of depressed patients. Psychiatry Res 1987; 22:265-273
42. Magliozzi JR, Gietzen D, Maddock RJ, Haack D, Doran AR, Goodman T, Weiler PG: Lymphocyte beta-adrenoceptor density in patients with unipolar depression and normal controls. Biol Psychiatry 1989; 26:15-25
43. Jeanningros R, Mazzola P, Azorin JM, Samuelian-Massa C, Tissot R: β-Adrenoceptor density of intact mononuclear leukocytes in subgroups of depressive disorders. Biol Psychiatry 1991; 29: 789-798
44. Mazzola-Pomietto P, Azorin JM, Tramoni V, Jeanningros R: Relation between lymphocyte β-adrenergic responsivity and the severity of depressive disorders. Biol Psychiatry 1994; 35:920-925
45. Mann JJ, Brown RP, Halper JP, Sweeney JA, Kocsis JH, Stokes PE, Bilezikian JP: Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation. N Engl J Med 1985; 313:715-720
46. Ebstein RP, Lerer B, Shapira B, Shemesh Z, Moscovich DG, Kindler S: Cyclic AMP second-messenger signal amplification in depression. Br J Psychiatry 1988; 152:665-669
47. Halper JP, Brown RP, Sweeney JA, Kocsis JH, Peters A, Mann JJ: Blunted β-adrenoceptor responsivity of peripheral blood mononuclear cells in endogenous depression: isoproterenol dose-response studies. Arch Gen Psychiatry 1988; 45:241-244
48. Mumby SM, Kahn RA, Manning DR, Gilman AG: Antisera of designed specificity for subunits of guanine nucleotide binding regulatory proteins. Proc Natl Acad Sci USA 1986; 83:265-269
49. Maddock RJ, Cameron CS, Magliozzi JR, Gietzen DW: Evidence that decreased function of lymphocyte β adrenoceptors reflects regulatory and adaptive processes in panic disorder with agoraphobia. Am J Psychiatry 1993; 150:1219-1225
50. Avissar S, Schreiber G: Differential receptor-coupled G proteins measures in leukocytes of patients with major (DSM-III-R axis I) mental disorders (abstract). Neuropsychopharmacology 1994; 10:5795